FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for the prevention of non-alcoholic fatty liver disease in patients with cholelithiasis after laparoscopic cholecystectomy. Treatment is carried out, including Ursofalk, Mucofalk, and Chophytol. Take Ursofalk 10 mg/kg of body weight at night, Mucofalk – 1 sachet of 5 g 3 times a day for 15 minutes before meals, duration of admission both Ursofalk, and Mucofalk is 2 months after the surgery, then take Chophytol 2 tablets 3 times a day for a month. Course of prevention is repeated after 3 months.
EFFECT: method allows to reduce the incidence of fatty liver disease in patients with cholelithiasis after laparoscopic cholecystectomy.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| WAY OF MEDICAMENTAL CORRECTION OF 2 STAGE OF CHOLELITHIASIS AT PATIENTS WITH OPISTHORCHOSIS | 2008 |
|
RU2362564C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2011 |
|
RU2473342C1 |
| METHOD FOR PROPHYLAXIS AND TREATMENT OF CHOLELITHIASIS | 2001 |
|
RU2207149C2 |
| COMBINED AGENT CONTAINING UDCA, HYMECROMONE AND SILYMARIN (VERSIONS) | 2017 |
|
RU2738444C2 |
| PHARMACEUTICAL COMPOSITION BASED ON HEPATOPROTECTOR AND PREBIOTIC AND METHOD FOR PRODUCING AND APPLYING THE COMPOSITION | 2006 |
|
RU2318538C1 |
| METHOD OF TREATING PATIENTS WITH INTESTINAL DYSBACTERIOSIS | 2009 |
|
RU2400235C1 |
| METHOD FOR DEFICIENT BILE REPLACEMENT WITH EXTERNAL BILIARY DRAINAGE | 2013 |
|
RU2532404C1 |
| COMBINED AGENT CONTAINING UDCA AND HYMECROMONE (EMBODIMENTS) | 2017 |
|
RU2689798C1 |
